The Effects Of High-Dose Vitamin C On Non-Hodgkin Lymphoma Patients

Scientists at Thomas Jefferson University Hospital and Jefferson’s Kimmel Cancer Center have received approval for a first-of-its kind study on the effect high dose vitamin C has on non-Hodgkin lymphoma patients. Researchers from the Jefferson-Myrna Brind Center of Integrative Medicine and Kimmel Cancer Center in conjunction with the National Institutes of Health will study whether high doses of vitamin C can slow the progression of the deadly disease. [click link for full article]

More: continued here

Filed under: Lymphoma / Leukemia on January 3rd, 2008